ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The advanced development of molecular targeted therapy for hepatocellular carcinoma

Yan, Tao; Yu, Lingxiang; Zhang, Ning; Peng, Caiyun; Su, Guodong; Jing, Yi; Zhang, Linzhi; Wu, Tong; Cheng, Jiamin; Guo, Qian; Shi, Xiaoliang*; Lu, Yinying*南方医科大学; 5
Cancer Biology & Medicine2022-6DOI: 10.20892/j.issn.2095-3941.2021.0661
17被引8阅读
引用收藏
分享

摘要

Hepatocellular carcinoma (HCC), one of the most common malignant tumors in China, severely threatens the life and health of patients. In recent years, precision medicine, clinical diagnoses, treatments, and innovative research have led to important breakthroughs in HCC care. The discovery of new biomarkers and the promotion of liquid biopsy technologies have greatly facilitated the early diagnosis and treatment of HCC. Progress in targeted therapy and immunotherapy has provided more choices for precise HCC treatment. Multiomics technologies, such as genomics, transcriptomics, and metabolomics, have enabled deeper understanding of the occurrence and development mechanisms, heterogeneity, and genetic mutation characteristics of HCC. The continued promotion and accurate typing of HCC, accurate guidance of treatment, and accurate prognostication have provided more treatment opportunities and prolonged survival timelines for patients with HCC. Innovative HCC research providing an in-depth understanding of the biological characteristics of HCC will be translated into accurate clinical practices for the diagnosis and treatment of HCC.

学科与关键词

关键词
Hepatocellular carcinomaprecision medicineliquid biopsytargeted therapyimmunotherapy
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Cancer Biology & Medicine
发表日期
2022-06
卷期
第 19 卷, 第 6 期
页码
802-817
DOI
10.20892/j.issn.2095-3941.2021.0661
期刊收录
CSCD-C.CAST-P
成果收录
SCIE
资助标注
Science Technology and Innovation Committee of Shenzhen Municipality [2019N002]; Capital's Funds for Health Improvement and Research [Z181100001718075]

作者

  • Y

    Yan, Tao (第一作者)

    5 · chinese peoples liberat army gen hosp · 2 · southern med univ

  • Y

    Yu, Lingxiang

    2 · 5 · chinese peoples liberat army gen hosp

查看全部 12 位作者收起作者
  • Z

    Zhang, Ning

    5 · chinese peoples liberat army gen hosp

  • P

    Peng, Caiyun

    5 · chinese peoples liberat army gen hosp

  • S

    Su, Guodong

    5 · chinese peoples liberat army gen hosp

  • J

    Jing, Yi

    5 · chinese peoples liberat army gen hosp

  • Z

    Zhang, Linzhi

    5 · chinese peoples liberat army gen hosp

  • W

    Wu, Tong

    5 · chinese peoples liberat army gen hosp

  • C

    Cheng, Jiamin

    5 · chinese peoples liberat army gen hosp

  • G

    Guo, Qian

    2 · southern med univ

  • S

    Shi, Xiaoliang (通讯)

  • L

    Lu, Yinying (通讯)

    5 · chinese peoples liberat army gen hosp · 2 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417